Anixa Biosciences (ANIX) Total Liabilities (2010 - 2026)
Anixa Biosciences (ANIX) posted Total Liabilities of $603,000 for fiscal Q3 2026 (quarter ended Jul 31, 2026), down 73.1% from $2.24 million a year earlier and down 63.3% from the prior quarter.
Powered by 
Analysis
Anixa Biosciences (ANIX) Total Liabilities (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Oct 31, 2025), Anixa Biosciences' Total Liabilities came in at $919,000, down 66.0% from FY2024.
- Annual Total Liabilities shows a five-year compound annual growth rate of -5.0% (FY2020 to FY2025).
- In prior fiscal years, Anixa Biosciences' Total Liabilities was $2.7 million in FY2024 (+25.7%), $2.15 million in FY2023 (-2.8%), $2.21 million in FY2022 (+48.5%) and $1.49 million in FY2021 (+25.3%).
- The fiscal Q3 2026 figure stands as the lowest quarterly Total Liabilities in data going back to fiscal Q4 2010.
- On a year-over-year basis, Total Liabilities increased in four of the last seven quarters, with an average decline of 13.2%.
- The strongest year-over-year quarter for Total Liabilities in the past five years was fiscal Q4 2022, with growth of 48.5%; the weakest was fiscal Q3 2026, with a decline of 73.1%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 116.09 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 141.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 87.82 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 80.09 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 65.46 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.95 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 37.53 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 115.64 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 7.18 Bn |
| 10 | Anixa Biosciences | 101.33 Mn | 100.06 Mn | - | 603,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 603,000.00 |
| Apr 30, 2026 | 1.64 Mn |
| Oct 31, 2025 | 919,000.00 |
| Jul 31, 2025 | 2.24 Mn |
| Apr 30, 2025 | 2.07 Mn |
| Jan 31, 2025 | 2.19 Mn |
| Oct 31, 2024 | 2.70 Mn |
| Jul 31, 2024 | 2.22 Mn |
| Apr 30, 2024 | 1.77 Mn |
| Jan 31, 2024 | 1.77 Mn |
| Oct 31, 2023 | 2.15 Mn |
| Jul 31, 2023 | 1.99 Mn |
| Apr 30, 2023 | 1.69 Mn |
| Jan 31, 2023 | 1.39 Mn |
| Oct 31, 2022 | 2.21 Mn |
| Jul 31, 2022 | 1.66 Mn |
| Apr 30, 2022 | 1.39 Mn |
| Jan 31, 2022 | 2.00 Mn |
| Oct 31, 2021 | 1.49 Mn |
| Jul 31, 2021 | 1.21 Mn |
API Access
Anixa Biosciences Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();